Merus N.V.·4

Feb 26, 9:17 PM ET

Throsby Mark 4

4 · Merus N.V. · Filed Feb 26, 2020

Insider Transaction Report

Form 4
Period: 2020-02-24
Throsby Mark
EVP & Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Shares

    2020-02-24+87,621100,903 total
  • Exercise/Conversion

    Share Option (right to buy)

    2020-02-2447,8161,017 total
    Exp: 2023-10-30Common Shares (47,816 underlying)
  • Exercise/Conversion

    Share Option (right to buy)

    2020-02-243,3330 total
    Exp: 2020-09-04Common Shares (3,333 underlying)
  • Sale

    Common Shares

    2020-02-24$17.74/sh57,088$1,012,74143,815 total
  • Exercise/Conversion

    Share Option (right to buy)

    2020-02-245,0000 total
    Exp: 2022-06-17Common Shares (5,000 underlying)
  • Exercise/Conversion

    Share Option (right to buy)

    2020-02-2431,4720 total
    Exp: 2023-03-16Common Shares (31,472 underlying)
Footnotes (10)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  • [F10]Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on October 30, 2015.
  • [F2]Exercise prices are denominated in Euros and ranged from 1.93 to 7.20, with a weighted average of 4.81.
  • [F3]Amount represents the weighted average price of shares sold, which ranged from $17.07 to $18.56. Details of individual transactions are available upon request.
  • [F4]Exercise price is denominated in Euros at 1.93.
  • [F5]These options are fully vested.
  • [F6]Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on September 4, 2012.
  • [F7]Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on June 17, 2014.
  • [F8]Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on March 16, 2015.
  • [F9]Exercise price is denominated in Euros at 7.20.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION